Patents by Inventor Jyrki Lehtimaki

Jyrki Lehtimaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of 3-(1H-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration
    Patent number: 6495584
    Abstract: The present invention relates to a method for obtaining analgesia by administering 3-(1H-imidazol-4-ylmethyl)-indan-5-ol, its enetiomer or pharmaceutically acceptable ester or salt thereof to a mammal intraspinally, 3-(1H-imidazol-4-ylmethyl)-indan-5-ol, its enantiomer or a pharmaceutically acceptable ester or salt thereof can be administered intraspinally to a mammal obtaining analgesia without side-effects, such as sedation. The present invention also relates to a method for using the drug as an adjunct to anaesthesia by administering it intraspinally.
    Type: Grant
    Filed: March 26, 2001
    Date of Patent: December 17, 2002
    Assignee: Orion Corporation
    Inventors: Antti Haapalinna, Jyrki Lehtimäki, Tiina Leino, Timo Viitamaa, Raimo Virtanen
  • Imidazole derivatives
    Patent number: 6388090
    Abstract: An imidazole derivative of formula (I) or a pharmaceutically acceptable salt or derivative thereof. The compounds of formula I exhibit affinity for alpha2 adrenoceptors.
    Type: Grant
    Filed: January 12, 2001
    Date of Patent: May 14, 2002
    Assignee: Orion Corporation
    Inventors: Paavo Huhtala, Arto Karjalainen, Antti Haapalinna, Jyrki Lehtimäki, Arja Karjalainen, Raimo Virtanen
  • Polycyclic indanylimidazoles with alpha2 adrenergic activity
    Patent number: 6362211
    Abstract: A compound of formula I wherein R1 to R3, —A—, m and t are as defined in claim 1, or a pharmaceutically acceptable salt or ester thereof, useful as an alpha2 adrenergic agent.
    Type: Grant
    Filed: May 7, 2001
    Date of Patent: March 26, 2002
    Assignee: Orion Corporation
    Inventors: Jari Ratilainen, Paavo Huhtala, Arto Karjalainen, Arja Karjalainen, Antti Haapalinna, Raimo Virtanen, Jyrki Lehtimäki
  • New polycyclic indanylimidazoles with alpha2 adrenergic activity
    Publication number: 20020013356
    Abstract: A compound of formula I 1
    Type: Application
    Filed: May 7, 2001
    Publication date: January 31, 2002
    Inventors: Jari Ratilainen, Paavo Huhtala, Arto Karjalainen, Arja Karjalainen, Antti Haapalinna, Raimo Virtanen, Jyrki Lehtimaki
  • Imidazole derivatives
    Publication number: 20010056109
    Abstract: An imidazole derivative of formula (I) 1
    Type: Application
    Filed: January 12, 2001
    Publication date: December 27, 2001
    Inventors: Paavo Huhtala, Arto Karjalainen, Antti Haapalinna, Jyrki Lehtimaki, Arja Karjalainen, Raimo Virtanen